Influenza surveillance

被引:7
作者
Bednarska, Karolina [1 ]
Hallmann-Szelinska, Ewelina [1 ]
Kondratiuk, Katarzyna [1 ]
Brydak, Lidia B. [1 ]
机构
[1] Panstwowy Zaklad Higieny, Narodowy Inst Zdrowia Publicznego, Krajowy Osrodek Ds Grypy, Zaklad Badania Wirusow Grypy, Ul Chocimska 24, PL-00791 Warsaw, Poland
来源
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ | 2016年 / 70卷
关键词
influenza; surveillance system; National Influenza Centres;
D O I
10.5604/17322693.1199709
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Influenza surveillance was established in 1947. From this moment WHO (World Health Organization) has been coordinating international cooperation, with agoal of monitoring influenza virus activity, effective diagnostic of the circulating viruses and informing society about epidemics or pandemics, as well as about emergence of new subtypes of influenza virus type A. Influenza surveillance is an important task, because it enables people to prepare themselves for battle with the virus that is constantly mutating, what leads to circulation of new and often more virulent strains of influenza in human population. As vaccination is the most effective method of fighting the virus, one of the major tasks of GISRS is developing an optimal antigenic composition of the vaccine for the current epidemic season. European Influenza Surveillance Network (EISN) has also developed over the years. EISN is running integrated epidemiological and virological influenza surveillance, to provide appropriate data to public health experts in member countries, to enable them undertaking relevant activities based on the current information about influenza activity. In close cooperation with GISRS and EISN are National Influenza Centres-national institutions designated by the Ministry of Health in each country.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 8 条
[1]  
Brydak L., 2008, GRYPA PANDEMIA GRYPY, P1
[2]  
Brydak L. B., 2006, FAM MED PRIM CARE RE, V8, P848
[3]   INFLUENZA - GLOBAL SURVEILLANCE FOR EPIDEMIC AND PANDEMIC VARIANTS [J].
COX, NJ ;
BRAMMER, TL ;
REGNERY, HL .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1994, 10 (04) :467-470
[4]  
Goodman C., 2016, EFFECTIVE WOULD ANTI, P4
[5]   Influenza and the work of the World Health Organization [J].
Kitler, ME ;
Gavinio, P ;
Lavanchy, D .
VACCINE, 2002, 20 :S5-S14
[6]  
Potter C.W., 1998, TXB INFLUENZA, P3
[7]  
Romanowska M., 2007, NOWA KLIN, V14, P1166
[8]   Health impact of influenza in the United States [J].
Sullivan, KM .
PHARMACOECONOMICS, 1996, 9 :26-33